Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity. Wang D, Zou F, Li Y, Hu J, et al. Mol Ther Oncol 2024;32:200759.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang D, Zou F, Li Y, Hu J, et al. Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity. Mol Ther Oncol 2024;32:200759.
PMID: 38596298